Literature DB >> 4070916

Humoral and cellular immune responses to Onchocerca volvulus infection in humans.

B M Greene, A A Gbakima, E J Albiez, H R Taylor.   

Abstract

Onchocerciasis is one of the major filarial diseases affecting humans and a leading cause of blindness. Control of the disease by chemotherapy and by elimination of the vector is not feasible in most areas of endemicity. The host immune response is thought to play a major role in the pathogenesis of complications. However, there is no clear evidence of protective immunity to reinfection in individuals who continue to be exposed to infective larvae. Antigens of Onchocerca volvulus are complex and show extensive cross-reactivity with other filarial parasites of humans and animals. Infection in humans results in the production of precipitating and reaginic antibodies to the parasite and in increases in levels of immunoglobulins that have no apparent specificity for parasitic antigens. Chronic antigenic stimulation in the presence of an antibody response leads to increased levels of circulating immune complexes. Cell-mediated immunity to parasite-derived antigens, as measured by migration inhibition, lymphocyte blastogenesis, and delayed skin-test reactivity, is decreased during infection. In addition, there is a decrease in delayed skin-test reactivity and in lymphocyte blastogenesis in response to unrelated antigens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4070916     DOI: 10.1093/clinids/7.6.789

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

Review 1.  Molecular parasitology: progress towards the development of vaccines for malaria, filariasis, and schistosomiasis.

Authors:  S J Cryz
Journal:  Experientia       Date:  1991-02-15

2.  Immunoregulation in onchocerciasis. Functional and phenotypic abnormalities of lymphocyte subsets and changes with therapy.

Authors:  D O Freedman; A Lujan-Trangay; C Steel; C Gonzalez-Peralta; T B Nutman
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

3.  Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis.

Authors:  S P Graham; A J Trees; R A Collins; D M Moore; F M Guy; M J Taylor; A E Bianco
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Baseline characterization of epilepsy in an onchocerciasis endemic area of the Democratic Republic of Congo.

Authors:  Kevin G Burfeind; Jean-Marie K Kashama; Béatrice K Bora; Charles F Murchison; Ana L Ramos-Crawford; Mambulu T Nseka; Shako B Kunyu; Daniel L Okitundu; Nicole L Mashukano; Jean-Pierre M Banea; J Boivin Michael; Jean-Claude K Mwanza; Dieudonne Mumba; Desire D Tshala-Katumbay
Journal:  Brain Res Bull       Date:  2018-11-20       Impact factor: 4.077

5.  Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors:  P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  Onchocerciasis modulates the immune response to mycobacterial antigens.

Authors:  G R Stewart; M Boussinesq; T Coulson; L Elson; T Nutman; J E Bradley
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

Review 7.  Helminth infections and host immune regulation.

Authors:  Henry J McSorley; Rick M Maizels
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Altered immune response (humoral and delayed-type hypersensitivity reactions) to sheep red blood cells in the course of experimental filarial infections (Litomosoides carinii, Brugia malayi, Acanthocheilonema viteae) of Mastomys natalensis.

Authors:  H Zahner; I Sänger; R K Chatterjee; G Seibold
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

9.  Tigemonam, an oral monobactam.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

10.  Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.

Authors:  P T Soboslay; C M Dreweck; W H Hoffmann; C G Lüder; C Heuschkel; H Görgen; M Banla; H Schulz-Key
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.